Learning objectives:         

After attending this symposium, participants should be able to:

• Review the current management strategies for metastatic hormone-sensitive prostate cancer (mHSPC) to optimise patient care
• Discuss the impact of new data on treatment and management decisions forindividual patients with non-metastatic castration-resistant prostate cancer(nmCRPC) and metastatic castration-resistant prostate cancer (mCRPC)
• Describe considerations ...

Learning objectives:         

After attending this symposium, participants should be able to:

• Highlight the importance of intrinsic and acquired EGFR resistance mutations in NSCLC and how this can impact patient outcomes
• Understand the increasing role of genetic and molecular profiling and biomarkers in tailoring therapy
• Describe how current and future research in the ...

Learning objective:         

After joining this meeting, participants should be able to:

• Describe the clinical benefits of earlier treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC) and non-metastatic castration-resistant prostate cancer (nmCRPC) and the consequences of disease progression
• Discuss the impact of new data on treatment and management decisions for ...

Learning objectives:         

After watching this broadcast, participants should be able to:

• Discuss and explain the new data on prostate cancer
• Discuss how the new data will affect daily clinical practice

Scientific committee:

• Heather Payne, UK
• Kurt Miller, Germany

Learning objectives:         

After watching this broadcast, participants should be able to:

• Discuss and explain the new data on prostate cancer
• Discuss how the new data will affect daily clinical practice

Scientific committee:

• Heather Payne, UK
• Kurt Miller, Germany

Learning objective:         

After watching this broadcast, participants should be able to:

• Evaluate the management options for advanced prostate cancer patients during the current COVID-19 pandemic
• Discuss the impact of the COVID-19 pandemic on patients and HCPs

Scientific committee:

• Heather Payne, UK
• Kurt Miller, Germany